2026 Regular Session
HB3834
Ibogaine clinical trials; Oklahoma Breakthrough Therapy Act; terms; requirements for drug developers; contractual terms; intellectual property rights; reports; intellectual property account; effective date.
Legislative progress
i
This summary includes only completed milestones supported by recorded actions. It does not predict the next step, and it preserves later committee reassignments, concurrence, conference, veto, and approval actions when they occur.
Partner positions
Likes
Procedures to allow for clinical trials for Ibogaine alkaloid orally given once for PTSD and brain injuries in Okla. (using in Mexico with good success rate).
Recorded floor votes
7 roll calls are available for this bill. This record includes procedural and intermediate action as well as substantive final votes.
February 11, 2026 · House
House: Public Health Committee: DO PASS
Passed
5 yea–0 nay
February 19, 2026 · House
House: Health and Human Services Oversight Committee: DO PASS
Passed
10 yea–0 nay
March 11, 2026 · House
House: THIRD READING
Passed ⭐ Substantive final action
68 yea–23 nay · 8 absent
April 13, 2026 · Senate
Senate: Health & Human Services Committee: DO PASS
Passed
10 yea–2 nay
April 22, 2026 · Senate
Senate: Appropriations Committee: DO PASS AMENDED CS
Passed
20 yea–0 nay
April 29, 2026 · Senate
Senate: THIRD READING
Passed ⭐ Substantive final action
33 yea–9 nay · 6 absent
May 6, 2026 · House
House: FOURTH READING
Passed
69 yea–21 nay · 9 absent
Committee referrals
April 13, 2026 · Senate
Appropriations
April 1, 2026 · Senate
Health and Human Services
February 3, 2026 · House
Public Health
February 3, 2026 · House
Health and Human Services Oversight
Instrument history
i
This is the complete recorded action history in the current source package. Highlighted entries are marked as significant by the source. A roll-call link appears only when a vote-like action has one unambiguous same-day chamber vote.
-
House Approved by Governor 05/12/2026
-
House Sent to Governor
-
Senate Enrolled measure signed, returned to House
-
House Enrolled, signed, to Senate
-
House Referred for enrollment
-
House Fourth Reading, Measure passed: Ayes: 69 Nays: 21 View roll call
-
House SA's read, adopted View roll call
-
House SA's received
-
Senate Engrossed to House
-
Senate Referred for engrossment
-
Senate Measure passed: Ayes: 33 Nays: 9 View roll call
-
Senate General Order, Considered
-
Senate Placed on General Order
-
Senate Reported Do Pass, amended by committee substitute Appropriations committee; CR filed View roll call
-
Senate Referred to Appropriations
-
Senate Reported Do Pass Health and Human Services committee; CR filed View roll call
-
Senate Second Reading referred to Health and Human Services Committee then to Appropriations Committee
-
Senate First Reading
-
House Engrossed, signed, to Senate
-
House Referred for engrossment
-
House Third Reading, Measure passed: Ayes: 68 Nays: 23 View roll call
-
House Amended
-
House General Order
-
House CR; Do Pass Health and Human Services Oversight Committee View roll call
-
House Authored by Senator Frix (principal Senate author)
-
House Coauthored by Representative(s) Pae
-
House Policy recommendation to the Health and Human Services Oversight committee; Do Pass Public Health View roll call
-
House Referred to Public Health
-
House Second Reading referred to Health and Human Services Oversight
-
House Authored by Representative May
-
House First Reading